# CARBAMAZEPINE

NDC: 62332-731
Generic name: CARBAMAZEPINE
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20241231

FDA application: ANDA216623

## Active ingredients

- CARBAMAZEPINE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-731"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-731
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87d343a8-84d5-4cdd-b0a0-629311b51f11